EMSAM Drug Patent Profile

✉ Email this page to a colleague

When do Emsam patents expire, and when can generic versions of Emsam launch?

Emsam is a drug marketed by Somerset and is included in one NDA.

The generic ingredient in EMSAM is selegiline. There are seventeen drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the selegiline profile page.

AI Research Assistant

Questions you can ask:

What is the 5 year forecast for EMSAM?
What are the global sales for EMSAM?
What is Average Wholesale Price for EMSAM?

Summary for EMSAM

US Patents:	0
Applicants:	1
NDAs:	1
Finished Product Suppliers / Packagers:	1
Raw Ingredient (Bulk) Api Vendors:	31
Patent Applications:	4,540
Drug Prices:	Drug price information for EMSAM
What excipients (inactive ingredients) are in EMSAM?	EMSAM excipients list
DailyMed Link:	EMSAM at DailyMed

Drug patent expirations by year for EMSAM

Pharmacology for EMSAM

Drug Class	Monoamine Oxidase Inhibitor Monoamine Oxidase Type B Inhibitor
Mechanism of Action	Monoamine Oxidase Inhibitors Monoamine Oxidase-B Inhibitors

US Patents and Regulatory Information for EMSAM

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Subscribe
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Somerset	EMSAM	selegiline	FILM, EXTENDED RELEASE;TRANSDERMAL	021336-001	Feb 27, 2006		RX	Yes	Yes	⤷ Subscribe	⤷ Subscribe				⤷ Subscribe
Somerset	EMSAM	selegiline	FILM, EXTENDED RELEASE;TRANSDERMAL	021336-002	Feb 27, 2006		RX	Yes	No	⤷ Subscribe	⤷ Subscribe				⤷ Subscribe
Somerset	EMSAM	selegiline	FILM, EXTENDED RELEASE;TRANSDERMAL	021336-003	Feb 27, 2006		RX	Yes	No	⤷ Subscribe	⤷ Subscribe				⤷ Subscribe
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for EMSAM

Subscribe to access the full database, or Subscribe
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Somerset	EMSAM	selegiline	FILM, EXTENDED RELEASE;TRANSDERMAL	021336-003	Feb 27, 2006	⤷ Subscribe	⤷ Subscribe
Somerset	EMSAM	selegiline	FILM, EXTENDED RELEASE;TRANSDERMAL	021336-002	Feb 27, 2006	⤷ Subscribe	⤷ Subscribe
Somerset	EMSAM	selegiline	FILM, EXTENDED RELEASE;TRANSDERMAL	021336-003	Feb 27, 2006	⤷ Subscribe	⤷ Subscribe
Somerset	EMSAM	selegiline	FILM, EXTENDED RELEASE;TRANSDERMAL	021336-001	Feb 27, 2006	⤷ Subscribe	⤷ Subscribe
Somerset	EMSAM	selegiline	FILM, EXTENDED RELEASE;TRANSDERMAL	021336-002	Feb 27, 2006	⤷ Subscribe	⤷ Subscribe
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

International Patents for EMSAM

See the table below for patents covering EMSAM around the world.

Subscribe to access the full database, or Subscribe
Country	Patent Number	Title	Estimated Expiration
European Patent Office	0406488		⤷ Subscribe
Canada	1329132	METHODE D'ADMINISTRATION DU DEPRENYL, PERMETTANT DE REDUIRE AU MINIMUM LES EFFETS SECONDAIRES DU PRODUIT (METHOD FOR ADMINISTERING THE DRUG DEPRENYL SO AS TO MINIMIZETHE DANGER OF SIDE EFFECTS)	⤷ Subscribe
Japan	H1160475	ADHESIVE MIXTURE FOR TRANSCUTANEOUS DISTRIBUTION OF HIGHLY PLASTIC AGENT	⤷ Subscribe
European Patent Office	0887075		⤷ Subscribe
China	1048320		⤷ Subscribe
>Country	>Patent Number	>Title	>Estimated Expiration

AI Research Assistant

Questions you can ask:

Summary for EMSAM

Pharmacology for EMSAM

Make Better Decisions: Try a trial or see plans & pricing